Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Tuesday, August 12, 2025
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Pharma
Pharma
Pharma
Study Points to New Mechanism for Schizophrenia Drug Candidate Evenamide
Life Sciences Times
-
August 11, 2025
Pharma
KalVista Drug for Hereditary Angioedema Keeps Orphan Status in EU
Life Sciences Times
-
August 11, 2025
Pharma
First Patient Dosed in Phase 3 Trial of Potential Dravet Syndrome Treatment
Life Sciences Times
-
August 11, 2025
Pharma
Palleon Pharmaceuticals Doses First Patient in Phase 2 Trial of E-602 for Autoimmune Kidney Disease
Life Sciences Times
-
August 7, 2025
Pharma
Astria Therapeutics Strikes $32 Million Licensing Deal with Kaken Pharmaceutical for HAE Drug in Japan
Life Sciences Times
-
August 6, 2025
Pharma
Oncodesign and TiumBio Sign Collaboration Agreement for R&D of Fibrosis Drug Candidates
Life Sciences Times
-
October 21, 2021
0
Pharma
Agilent PD-L1 IHC 28-8 pharmDx Receives CE-IVD Mark as a Companion Diagnostic Test in Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
Life Sciences Times
-
October 21, 2021
0
Pharma
Mablink Bioscience and Emergence Therapeutics Enter Into a Licensing Agreement to Develop Antibody Drug Conjugate as a Potential Cancer Therapy
Life Sciences Times
-
October 21, 2021
0
Pharma
Prilenia and Huntington Study Group Announce Completion of Patient Enrollment Ahead of Schedule in Global Phase 3 PROOF-HD Huntington’s Disease Clinical Trial
Life Sciences Times
-
October 20, 2021
0
Pharma
BeiGene and Nanolek Announce Approval in Russia for BRUKINSA® (Zanubrutinib) for Treatment of Patients with Relapsed or Refractory Mantle Cell Lymphoma
Life Sciences Times
-
October 20, 2021
0
Pharma
Boehringer Ingelheim and Partners to Accelerate Development of First-In-Class Gene Therapy for Patients with Cystic Fibrosis
Life Sciences Times
-
October 19, 2021
0
Pharma
FSD Pharma Signs Agreement with Covar Pharmaceuticals to Support the Development of Lucid-PSYCH
Life Sciences Times
-
October 19, 2021
0
Pharma
U.S. Food and Drug Administration Approves Expanded Indication of Gilead’s Biktarvy® for Treatment of HIV-1 in Pediatric Populations
Life Sciences Times
-
October 18, 2021
0
Pharma
Sacituzumab Govitecan Receives Positive CHMP Opinion as 2L Treatment for Adult Patients With Metastatic Triple-Negative Breast Cancer
Life Sciences Times
-
October 15, 2021
0
Pharma
Rhizen Pharmaceuticals AG Announces First Patient Dosing in a Phase II Study of Tenalisib (RP6530) in Locally Advanced or Metastatic Breast Cancer Patients
Life Sciences Times
-
October 14, 2021
0
Pharma
Exelixis In-Licenses Second Anti-Cancer Compound from Aurigene Following FDA Acceptance of Investigational New Drug
Life Sciences Times
-
October 14, 2021
0
Pharma
VBI Vaccines Announces Publication of Results from Pivotal Phase 3 Study, CONSTANT, of VBI’s Prophylactic 3-Antigen Hepatitis B Vaccine Candidate
Life Sciences Times
-
October 13, 2021
0
1
...
55
56
57
...
76
Page 56 of 76
Most Read
First FDA-Approved Treatment for MacTel Administered Following Commercial Launch
August 11, 2025
Study Points to New Mechanism for Schizophrenia Drug Candidate Evenamide
August 11, 2025
FDA Clears Thermo Fisher Test to Match Lung Cancer Patients With Newly Approved HER2-Targeted Drug
August 11, 2025
SetPoint Medical Secures $140 Million to Advance Rheumatoid Arthritis Therapy, Expands Leadership Team
August 11, 2025